Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5561-5570 Newer>

Pharmaceutical Executive April 1, 2009 Joanna Breitstein	Millennium's Deborah Dunsire: Woman of the Year From her start as a physician working in apartheid-era South Africa, to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.
Pharmaceutical Executive April 1, 2009 S. Kent Stephan	Retooling the Pharma Marketing Model It's time for pharma market research to advance science-based decisions and foster judgement calls.
Pharmaceutical Executive April 1, 2009 Stan Bernard	When Sharks Attack Launching a new drug? Your competition likely plans to interfere. Here's how to counter a counter-launch.
Pharmaceutical Executive April 1, 2009 Patrick Clinton	Dear Commissioner... Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.
Pharmaceutical Executive April 1, 2009 Jill Wechsler	Kickoff for Reform In addition to overhauling healthcare, Congress is weighing proposals for updating FDA policies and expanding access to drugs.
Fast Company May 2009 Chuck Salter	The Doctor of the Future Cost, access, quality -- the prognosis for American health care may look grim, but innovation is the cure. The medicine of tomorrow is being born today.
Fast Company May 2009 Ellen McGirt	Why Electronic Health Records Are Worth the Hype -- and the Price The push for electronic medical records has stirred controversy -- but their potential is immeasurable.
Fast Company May 2009 Elizabeth Svoboda	Biotechs Wage War on Superbugs With antibiotic resistance on the rise, three biotechs are developing new ways to wage war on superbugs.
The Motley Fool April 15, 2009 Brian Orelli	Abbott's on Sale Abbott isn't firing on all cylinders the way it was last year, but things still look fine, and the stock is selling at a discount right now.
The Motley Fool April 15, 2009 Brian Orelli	Johnson & Johnson Still Withstands Recession While Johnson & Johnson is big, it has proven to be agile during the recession, and this quarter was no different.
<Older 5561-5570 Newer> Return to current articles.